These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 3499613)

  • 21. Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides.
    Gao WY; Hanes RN; Vazquez-Padua MA; Stein CA; Cohen JS; Cheng YC
    Antimicrob Agents Chemother; 1990 May; 34(5):808-12. PubMed ID: 2163243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.
    Lee DS; Jung KE; Yoon CH; Lim H; Bae YS
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4110-20. PubMed ID: 16189087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.
    Agrawal S; Ikeuchi T; Sun D; Sarin PS; Konopka A; Maizel J; Zamecnik PC
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7790-4. PubMed ID: 2682627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.
    Henderson GB; Stein CA
    Nucleic Acids Res; 1995 Sep; 23(18):3726-31. PubMed ID: 7479003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
    Lund OS; Nielsen JO; Hansen JE
    Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorothioate oligodeoxynucleotides are potent sequence nonspecific inhibitors of de novo infection by HIV.
    Stein CA; Matsukura M; Subasinghe C; Broder S; Cohen JS
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):639-46. PubMed ID: 2482061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs.
    Azad RF; Brown-Driver V; Buckheit RW; Anderson KP
    Antiviral Res; 1995 Oct; 28(2):101-11. PubMed ID: 8585764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
    Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents.
    Iyer RP; Uznanski B; Boal J; Storm C; Egan W; Matsukura M; Broder S; Zon G; Wilk A; Koziolkiewicz M
    Nucleic Acids Res; 1990 May; 18(10):2855-9. PubMed ID: 2349087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral effects on mouse leukemia virus replication by oligodeoxynucleotides in vitro and in vivo.
    Shan YF; Gao HY; Ji H; Qiu MS; Wang DB
    Chin Med J (Engl); 1994 Feb; 107(2):146-50. PubMed ID: 8194383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
    Anazodo MI; Wainberg MA; Friesen AD; Wright JA
    J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine.
    Gao WY; Jaroszewski JW; Cohen JS; Cheng YC
    J Biol Chem; 1990 Nov; 265(33):20172-8. PubMed ID: 2173699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
    Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
    Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA
    AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
    Hayashi S; Phadtare S; Zemlicka J; Matsukura M; Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6127-31. PubMed ID: 3261865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
    Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
    Matsukura M; Zon G; Shinozuka K; Robert-Guroff M; Shimada T; Stein CA; Mitsuya H; Wong-Staal F; Cohen JS; Broder S
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4244-8. PubMed ID: 2471199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.
    Balotta C; Lusso P; Crowley R; Gallo RC; Franchini G
    J Virol; 1993 Jul; 67(7):4409-14. PubMed ID: 8510229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
    Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
    Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.